Neuroferritinopathy.

Alexander Lehn, Richard Boyle, Helen Brown, Caroline Airey, George Mellick

Journal: Parkinsonism & related disorders 2013;18(8):909-15

PMID: 22818529

Abstract

Neuroferritinopathy is an autosomal dominantly inherited disorder caused by mutations in the gene encoding the ferritin light chain polypeptide. It leads to iron deposition particularly in the cerebellum, basal ganglia and motor cortex. The disease becomes clinically apparent in adulthood mainly with extrapyramidal signs and progresses slowly over decades. Patients usually have intact cognition until the very late stages of this disorder. Neuroimaging is the most helpful investigation and shows a very distinctive picture. So far no medication has been shown to have a disease-modifying effect. We present five new cases of this condition and review the current understanding of the pathogenesis and its clinical findings.

Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Address: Department of Neurology, Princess Alexandra Hospital, Brisbane, Queensland, Australia. [email protected]
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.